The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Chronic Cough Global Market Report 2023, The global chronic cough market is expected to grow from $6.88 billion in 2022 to $7.50 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The chronic cough market is expected to reach $10.43 billion in 2027 at a CAGR of 8.6%.

What was the major driver in the chronic cough market?
The rise in the prevalence of cough is expected to propel the growth of the chronic cough market going forward. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 2,390 cases of whooping cough were found in 2020, and 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries. Furthermore, in March 2022, according to the Statens Serum Institut, a Denmark-based department of disease surveillance, the number of pertussis cases recorded increased by 41% from November 2022 to April 2023, compared to November 2021–April 2022 in Denmark. Therefore, the rise in the prevalence of cough is driving the growth of the chronic cough market.

View More On The Chronic Cough Market Report 2023 –
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

What was the key trend in the chronic cough market?
Product innovation has emerged as a key trend gaining popularity in the chronic cough market. Major companies operating in the chronic cough market are concentrating on creating innovative products to strengthen their position in the market. For instance, in October 2020, GSK Consumer Healthcare, a UK-based pharmaceutical and biotechnology company, launched Robitussin Naturals, a drug-free product that relieves occasional long-term cough. Robitussin users and proponents of natural wellness products are made with natural components to give people confidence in their solutions to treat spasmodic coughs. The first-of-their-kind, drug-free dietary supplements developed by the experts in coughs, Robitussin Naturals Cough Relief Syrup and Robitussin Naturals Cough Relief + Immune Health Syrup, help relieve spasmodic coughs brought on by irritation, dry throat, or hoarseness. The convenient chewable version of Robitussin Naturals Gummies also contains components from naturally produced sources.

Which was the largest region in the chronic cough market?
North America was the largest region in the chronic cough market in 2022. The regions covered in chronic cough report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the chronic cough market prominent players?
Major players in the chronic cough market are Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca plc; Glaxo SmithKline Plc; Merck KGaA; Reckitt Benckiser Group plc; Glenmark Pharmaceuticals Ltd; Teva Pharmaceutical Industries Ltd.; Mylan NV; Aurobindo Pharma Ltd.; Cipla Limited; Apotex Inc.; Hikma Pharmaceuticals Plc; Amneal Pharmaceuticals LLC; Mount Sinai Health System; Biocon Ltd.; BELLUS Health Inc.; Trevi Therapeutics Inc.; Sun Pharmaceutical Industries Ltd.; and NeRRe Therapeutics Ltd.

Key chronic cough market segments

The global chronic cough market is segmented –

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes

2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations

3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Request A Sample Of The Global Chronic Cough Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12109&type=smp

The Chronic Cough Global Market Report 2023  provides a comprehensive overview on the chronic cough market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Cough And Cold Preparations Global Market Report 2023
Aromatherapy Global Market Report 2023
Throat Lozenges Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model